Reporting of race and ethnicity at an international haematology conference.

Summary

Only 13% of clinical presentations at a major international hematology conference reported the race of their study participants. This widespread underreporting obscures racial disparities in cancer care and limits the generalizability of clinical findings across diverse patient populations.

Key result

Only 74 of 560 clinical studies (13%) presented at the 61st Annual Meeting of the American Society of Hematology discussed race as a demographic feature, with studies from outside the US significantly less likely to report this data (odds ratio 0.18; 95% confidence interval 0.09–0.37; P < 0.001).

Key figure